Yuval Cohen - 26 Jan 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Chief Executive Officer, Director
Signature
/s/ Yuval Cohen
Issuer symbol
CRBP
Transactions as of
26 Jan 2024
Net transactions value
$0
Form type
4
Filing time
30 Jan 2024, 16:56:07 UTC
Previous filing
11 Aug 2022
Next filing
14 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBP Common Stock Options Exercise $35,680 +7,179 $4.97 7,179 26 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Options to purchase common stock Options Exercise $35,680 -7,179 -100% $4.97 0 26 Jan 2024 Common stock 7,179 $4.97 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.